Open-Label, Fixed-Sequence Study To Estimate The Pharmacokinetic Interaction Between Multiple Dose Maraviroc And Fosamprenavir/Ritonavir In Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 28 Apr 2014
At a glance
- Drugs Maraviroc (Primary) ; Fosamprenavir; Ritonavir
- Indications HIV infections; Hypertriglyceridaemia
- Focus Pharmacokinetics
- Sponsors ViiV Healthcare
- 28 Jun 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 03 Jun 2011 Planned End Date changed from 1 May 2011 to 1 Jun 2011 as reported by ClinicalTrials.gov.
- 04 May 2011 Actual initiation date (April 2011) added as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History